Home › Funds › CenterBook Partners LP › MLYS

CenterBook Partners LP position in MLYS

Mineralys Therapeutics, Inc. · Health Care

CenterBook Partners LP reported holding 365,630 shares of MLYS (Mineralys Therapeutics, Inc.) in its Q2 2026 13F filing — a position valued at US$9.9M, representing 0.48% of its reported portfolio and ranking #39 among its reported holdings. CenterBook Partners LP has disclosed MLYS holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)365.63K sh
Reported value held$9.86M
Portfolio Weight0.48%
First reportedQ4 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How CenterBook Partners LP's MLYS position evolved

CenterBook Partners LP first disclosed a stake in MLYS in Q4 2025 at 26,000 shares (US$944K). The position peaked in Q2 2026 at 365,630 shares, worth US$9.9M. Across 3 filings, CenterBook Partners LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 365,630 shares valued at US$9.9M — an increase of 276,300 shares quarter over quarter.. Notable position changes include a 244% increase in Q1 2026 (shares were roughly flat over the following quarter), a 309% increase in Q2 2026 (shares fell 7% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 26.00K $943.54K New
Q1 2026 89.33K $2.42M Add
Q2 2026 365.63K $9.86M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MLYS and 13F data

MLYS (Mineralys Therapeutics, Inc.) is a Health Care company. 54 other funds we track also report a position in MLYS — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$207.6M), Catalys Pacific, LLC (US$196.0M), Samsara BioCapital, LLC (US$158.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MLYS

All MLYS fund holders →

FAQ

How long has CenterBook Partners LP held MLYS?

CenterBook Partners LP has disclosed MLYS holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is CenterBook Partners LP's current position in MLYS?

As of Q2 2026, CenterBook Partners LP holds 365.63K shares of MLYS (Mineralys Therapeutics, Inc.), valued at $9.86M, representing 0.48% of its reported portfolio and ranking #39.

Has CenterBook Partners LP been buying or selling MLYS?

In the latest 13F filing (Q2 2026), CenterBook Partners LP increased its position in MLYS. The position peaked in Q2 2026 at 365.63K shares.

Which other funds hold MLYS?

Other major institutional holders of MLYS include RA CAPITAL MANAGEMENT, L.P., Catalys Pacific, LLC, Samsara BioCapital, LLC, among 54 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.